Article citationsMore >>

Olatunbosun OA, Abasiattai AM, Bassey EA, James RS, Ibanga G, Morgan A. Prevalence of anaemia among pregnant women at booking in the university of Uyo Teaching Hospital, Uyo, Nigeria. Biomed Res Int 2014; 2014: 8.

has been cited by the following article:

Article

Second Trimester Uterine Artery Doppler Study as a Predictor of Preeclampsia and Intrauterine Growth Restriction

1Department of Obstetrics and Gynaecology, Alex Ekwueme Federal University Teaching Hospital, Abakaliki; Nigeria

2Department of Radiology, Alex Ekwueme Federal University Teaching Hospital, Abakaliki; Nigeria


American Journal of Clinical Medicine Research. 2024, Vol. 12 No. 1, 1-12
DOI: 10.12691/ajcmr-12-1-1
Copyright © 2024 Science and Education Publishing

Cite this paper:
Chidiebere Vincent Ali, Boniface N Ejikeme, Eziaha E Ede, Michael Okoh Orji, Ayodele Adegbite Olaleye, John C Irechukwu, Nwabunike Ekene Okeke, Chidi Ikenna Ebere, Emmanuel Onyekelu. Second Trimester Uterine Artery Doppler Study as a Predictor of Preeclampsia and Intrauterine Growth Restriction. American Journal of Clinical Medicine Research. 2024; 12(1):1-12. doi: 10.12691/ajcmr-12-1-1.

Correspondence to: Ayodele  Adegbite Olaleye, Department of Obstetrics and Gynaecology, Alex Ekwueme Federal University Teaching Hospital, Abakaliki; Nigeria. Email: ayodele_olaleye@yahoo.com

Abstract

Background: Impaired placentation with its associated increased impedance to blood flow in the uterine arteries is associated with complications in pregnancy such as pre-eclampsia and intra-uterine growth restriction (IUGR) among others. These complications are identified causes of maternal/perinatal morbidity and mortality. The uterine artery Doppler has potentials for screening for these pathological processes that are associated with impaired placentation. Objective: This study was designed to evaluate the predictive value of Doppler investigations of the uterine circulation in the second trimester (20-24 weeks of gestation) with regard to the development of some pregnancy complications such as pre-eclampsia and IUGR. Methods: This was a prospective longitudinal cross-sectional study of 354 low-risk women attending antenatal care at Alex Ekwueme Federal University Teaching Hospital Abakaliki. The study population was subjected to uterine artery Doppler study at 20-24 weeks gestation. The mean uterine artery Doppler indices such as pulsatitity index (PI), resistance index (RI) and presence of early diastolic notch (EDN) were obtained, and the outcomes of pre-eclampsia and intra-uterine growth restriction (IUGR) were studied. Data analysis was done using statistical package for social science (IBMSPSS) software (version 21, Chicago II, USA) at a statistical significance level of p < 0.05. Results: Out of the 354 women, 21(5.9%) developed pre-eclampsia and 27 (7.6% developed intra-uterine growth restriction. For pre-eclampsia, the resistance index showed a sensitivity of 66.7%, specificity of 91.9%, positive predictive value (PPV) of 34.2% and negative predictive value (NPV) of 97.8%; its pulsatility index showed a sensitivity of 71.4%, specificity of 95.5%, PPV of 50.0% and NPV of 98.2%; while for early diastolic notch had sensitivity of 66.7%, specificity of 94.3%, PPV of 42.4% and NPV of 97.8%. For intra-uterine growth restriction, resistance index showed a sensitivity of 59.3%, specificity of 92.4%, PPV of 39.0% and NPV of 96.5%; pulsatility index showed a sensitivity of 77.8%, specificity of 97.3%, PPV of 70.0% and NPV of 98.2%; while early diastolic notch had a sensitivity of 85.2%, specificity of 96.9%, PPV of 69.7% and NPV of 98.8%. Conclusion: The high negative predictive values indicated that women with normal Doppler velocimetry were unlikely to develop pre-eclampsia or intra-uterine growth restriction. Uterine artery Doppler, being non-invasive, can be included during routine sonography to identify patients at risk of developing pre-eclampsia or intra-uterine growth restriction. Early screening for pre-eclampsia and intra-uterine growth restriction will help in individualized antenatal surveillance and initiation of prophylactic therapy, and will help to reduce the adverse maternal and foetal complications of pre-eclampsia and intra-uterine growth restriction.

Keywords